ARID1A mutations can be detected through various methods, including next-generation sequencing (NGS), immunohistochemistry (IHC), and polymerase chain reaction (PCR)-based techniques. NGS allows for comprehensive genomic profiling, while IHC can detect the loss of ARID1A protein expression in tissue samples. These methods help in the diagnosis and molecular characterization of cancers.
